Profile data is unavailable for this security.
About the company
AIM Vaccine Co Ltd is a China-based company principally engaged in the research and development, manufacturing and sales of vaccine. The Company's products mainly include recombinant hepatitis B vaccine, human rabies vaccine, inactivated hepatitis A vaccine, mumps vaccine, inactivated hemorrhagic fever with renal syndrome vaccine and MPSV4. The Company's products are mainly used for the treatment of hepatitis B, hepatitis A, mumps, hemorrhagic fever with renal syndrome, rabies and meningococcal diseases. The Company's vaccine candidates include messenger RNA (mRNA) corona virus disease 2019 (COVID-19) vaccine, inactivated COVID-19 vaccine, broad-spectrum COVID-19 vaccine, PCV13, PPSV23 and MCV4. The Company principally conducts its businesses in the domestic market.
- Revenue in HKD (TTM)1.28bn
- Net income in HKD-1.40bn
- Incorporated2011
- Employees1.62k
- LocationAIM Vaccine Co Ltd25/FBuilding A, 91 Jianguo Road, ChaoyangBEIJING 110000ChinaCHN
- Phone+86 1 085950621
- Websitehttps://www.aimbio.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China Shineway Pharmaceutical Group Ltd | 4.87bn | 1.05bn | 7.69bn | 3.44k | 6.72 | 1.01 | 6.28 | 1.58 | 1.38 | 1.38 | 6.45 | 9.18 | 0.5073 | 1.44 | 6.31 | 1,418,434.00 | 10.89 | 8.03 | 14.15 | 9.77 | 75.15 | 74.55 | 21.47 | 17.87 | 2.98 | -- | 0.0411 | 36.29 | 14.32 | 11.94 | 34.14 | 13.89 | 0.6396 | 12.88 |
| Beijing Tong Ren Tang Chinese Medicine | 1.52bn | 540.39m | 7.89bn | 798.00 | 14.59 | 2.04 | 11.72 | 5.17 | 0.6456 | 0.6456 | 1.82 | 4.62 | 0.3522 | 0.6449 | 2.31 | 1,910,959.00 | 13.64 | 16.71 | 15.50 | 18.75 | 68.67 | 69.88 | 38.73 | 40.72 | 8.59 | -- | 0.0317 | 68.87 | -11.91 | 0.1459 | -16.33 | -1.43 | -16.30 | 7.49 |
| Everest Medicines Ltd | 135.89m | -911.25m | 8.09bn | 432.00 | -- | 1.49 | -- | 59.52 | -2.91 | -2.91 | 0.4341 | 16.79 | 0.0203 | 2.25 | 4.57 | 314,563.90 | -13.63 | -30.52 | -15.06 | -33.14 | 72.67 | -- | -670.57 | -5,745.25 | 8.29 | -- | 0.0979 | -- | 884.46 | -- | -241.50 | -- | 4.65 | -- |
| Shanghai Henlius Biotech Inc | 5.82bn | 589.20m | 9.02bn | 3.64k | 15.36 | 3.81 | 9.24 | 1.55 | 1.08 | 1.08 | 10.67 | 4.35 | 0.5731 | 1.95 | 9.10 | 1,600,654.00 | 5.80 | -8.59 | 12.47 | -14.14 | 72.64 | 71.77 | 10.12 | -27.37 | 0.3786 | 6.48 | 0.6512 | -- | 67.82 | 273.51 | 178.53 | -- | 49.14 | -- |
| Cansino Biologics Inc | 372.48m | -1.60bn | 9.21bn | 1.49k | -- | 0.944 | -- | 24.73 | -6.48 | -6.48 | 1.51 | 23.04 | 0.0332 | 2.37 | 0.4619 | 249,318.30 | -18.93 | -4.27 | -26.69 | -5.60 | -253.78 | -- | -569.97 | -27.72 | 1.86 | -- | 0.3381 | -- | -66.52 | 213.94 | -63.04 | -- | 30.60 | -- |
| Keymed Biosciences Inc | 382.10m | -387.78m | 9.96bn | 897.00 | -- | 3.09 | -- | 26.06 | -1.49 | -1.49 | 1.45 | 11.52 | 0.0906 | 0.7314 | 26.14 | 425,974.80 | -9.16 | -- | -10.05 | -- | 89.59 | -- | -101.04 | -- | 9.18 | -- | 0.123 | -- | 253.87 | -- | -16.63 | -- | -- | -- |
| InnoCare Pharma Ltd | 796.95m | -681.19m | 10.49bn | 1.09k | -- | 1.22 | -- | 13.16 | -0.4039 | -0.4039 | 0.4723 | 4.37 | 0.073 | 1.39 | 3.39 | 731,814.40 | -6.38 | -13.41 | -8.08 | -15.36 | 82.61 | 85.99 | -87.42 | -172.16 | 4.13 | -- | 0.1582 | -- | 18.09 | 240.36 | 28.80 | -- | 66.20 | -- |
| Lepu Biopharma Co Ltd | 243.17m | -23.84m | 10.64bn | 429.00 | -- | 10.99 | 136.67 | 43.74 | -0.0144 | -0.0144 | 0.1465 | 0.5832 | 0.0917 | 1.06 | 1.62 | 566,840.30 | -1.23 | -- | -1.91 | -- | 87.45 | -- | -13.45 | -- | 0.7201 | 0.1388 | 0.4549 | -- | 1,347.16 | -- | 96.79 | -- | -- | -- |
| AIM Vaccine Co Ltd | 1.28bn | -1.40bn | 10.75bn | 1.62k | -- | 2.74 | -- | 8.39 | -1.16 | -1.16 | 1.06 | 3.25 | -- | -- | -- | 789,028.10 | -- | -- | -- | -- | 75.88 | -- | -164.24 | -- | 0.7583 | -14.04 | 0.3158 | -- | -6.06 | -- | -307.07 | -- | -- | -- |
| Luye Pharma Group Ltd | 6.63bn | 574.73m | 11.36bn | 5.27k | 19.67 | 0.8401 | 8.48 | 1.71 | 0.1535 | 0.1535 | 1.78 | 3.59 | 0.247 | 2.42 | 3.60 | 1,257,859.00 | 2.17 | 2.80 | 3.56 | 4.45 | 68.44 | 70.53 | 8.78 | 10.39 | 1.21 | 3.10 | 0.3931 | 11.82 | 2.70 | 3.50 | -11.94 | -16.39 | -14.05 | -- |
| SciClone Pharmaceuticals (Holdings) Ltd | 3.41bn | 1.21bn | 11.37bn | 1.05k | 9.75 | 3.22 | 14.89 | 3.34 | 1.86 | 1.86 | 5.24 | 5.62 | 0.7585 | 3.56 | 3.83 | 3,243,032.00 | 26.97 | 27.09 | 33.34 | 36.32 | 74.67 | 76.06 | 35.55 | 35.43 | 4.50 | 27.95 | 0.01 | -- | 14.76 | 17.50 | 31.16 | 15.96 | -- | -- |
| Yichang Hec Changjiang Pharmactcl Co Ltd | 6.79bn | 2.15bn | 11.44bn | 4.62k | 5.32 | 1.34 | 4.72 | 1.68 | 2.44 | 2.44 | 7.72 | 9.73 | 0.5111 | 3.62 | 4.00 | 1,470,855.00 | 15.07 | 8.03 | 24.46 | 11.81 | 79.21 | 79.97 | 29.48 | 20.80 | 1.30 | 9.32 | 0.2475 | -- | 68.08 | 20.18 | 2,501.24 | 16.15 | -- | -- |
| Zai Lab Ltd | 2.08bn | -2.61bn | 12.70bn | 2.18k | -- | 2.00 | -- | 6.09 | -2.70 | -2.70 | 2.16 | 6.40 | 0.2364 | 2.51 | 5.38 | -- | -29.66 | -37.72 | -34.97 | -42.72 | 64.08 | 64.75 | -125.46 | -282.44 | 4.41 | -- | 0.00 | -- | 24.03 | 360.03 | 24.51 | -- | -3.45 | -- |
| SSY Group Ltd | 6.46bn | 1.32bn | 14.19bn | 5.60k | 10.80 | 2.05 | 8.12 | 2.20 | 0.4427 | 0.4427 | 2.17 | 2.33 | 0.5637 | 3.00 | 3.01 | 1,154,109.00 | 11.59 | 10.51 | 15.58 | 14.03 | 56.01 | 58.72 | 20.57 | 18.62 | 1.60 | 29.61 | 0.317 | 38.56 | 0.4505 | 9.10 | 17.44 | 7.66 | 3.94 | 13.56 |
Data as of May 06 2024. Currency figures normalised to AIM Vaccine Co Ltd's reporting currency: Hong Kong Dollar HKD
6.54%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| China Merchants Wealth Asset Management Ltd.as of 19 Oct 2023 | 30.36m | 6.17% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 1.03m | 0.21% |
| China Asset Management (Hong Kong) Ltd.as of 28 Mar 2024 | 259.06k | 0.05% |
| TIAA-CREF Investment Management LLCas of 29 Feb 2024 | 166.60k | 0.03% |
| SSgA Funds Management, Inc.as of 04 Apr 2024 | 137.40k | 0.03% |
| BlackRock Advisors (UK) Ltd.as of 02 Apr 2024 | 108.40k | 0.02% |
| State Street Global Advisors Ltd.as of 04 Apr 2024 | 52.20k | 0.01% |
| BlackRock Institutional Trust Co. NAas of 04 Apr 2024 | 34.20k | 0.01% |
| China Asset Management Co., Ltd.as of 30 Jun 2023 | 30.60k | 0.01% |
| Legal & General Investment Management Ltd.as of 30 Sep 2023 | 5.20k | 0.00% |
More ▼
Data from 19 Oct 2023 - 02 May 2024Source: FactSet Research Systems Inc.
